Discover 2,379 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,379
Active & Responsive
Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations
for
Stimulant Use (Diagnosis)
Location: Chicago IL, Rockford IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT05702021
Recruiting
Active & Responsive
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
for
Hypertension, Acute Severe Hypertension, Hypertensive Emergency,
Location: Chicago IL, Beavercreek OH, Detroit MI, Cleveland OH,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07511361
Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Chicago IL, Carmel IN, Saint Charles MO, Cincinnati OH,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06830044
Phase 3, Recruiting
Active & Responsive
Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older
for
Obesity, Depression
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 50 - 70+
Code: NCT06636058
Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Chicago IL, Indianapolis IN, St Louis MO, Ann Arbor MI,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06578195
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Chicago IL, Ann Arbor MI, Cincinnati OH, Columbus OH,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07281079
Phase 3, Recruiting
Active & Responsive
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: Rolling Meadows IL, Milwaukee WI, Iowa City IA,
Sponsor: Disc Medicine, Inc
Sex: All
Age: 18+
Code: NCT05320198
Phase 1, Phase 2, Recruiting
Active & Responsive
Motiva Implants® Post-Approval Study
for
Breast Implant
Location: South Barrington IL, Chicago IL, St Louis MO,
Sponsor: Motiva USA LLC
Sex: Female
Age: 22+
Code: NCT06938399
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Chicago IL, Grand Rapids MI, Nashville TN, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
for
Acute Myeloid Leukemia, Relapsed, Adult,
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18 - 65
Code: NCT06802315
Phase 2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Chicago IL, Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Active & Responsive
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder, Opioid Use Disorder, Moderate,
Location: Chicago IL, Cape Girardeau MO, Huntington WV,
Sponsor: T. John Winhusen, PhD
Sex: All
Age: 18+
Code: NCT06651177
Phase 2, Recruiting
Active & Responsive
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
for
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Albuminuria
Location: Chicago IL, Ann Arbor MI, Columbus OH, Cleveland OH,
Sponsor: University of Michigan
Sex: All
Age: 0 - 70+
Code: NCT01209000
Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: Chicago IL, Louisville KY, Birmingham AL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06439082
Phase 3, Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension